Patents by Inventor Karl J.M. Hanf

Karl J.M. Hanf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-transferrin receptor antibodies and uses thereof
    Patent number: 11827702
    Abstract: The present disclosure provides anti-transferrin receptor antibodies, compositions comprising the same and methods of their use. This disclosure also provides polynucleotides and vectors encoding the anti-transferrin receptor antibodies and cells comprising the same, methods of making the antibodies, and molecules comprising the antibodies.
    Type: Grant
    Filed: August 31, 2022
    Date of Patent: November 28, 2023
    Assignee: Biogen MA Inc.
    Inventors: Isin Dalkilic-Liddle, Benjamin A. Smith, Karl J. M. Hanf, Fang Qian, R. Blake Pepinsky, Thomas O. Cameron
  • ANTI-TRANSFERRIN RECEPTOR ANTIBODIES AND USES THEREOF
    Publication number: 20230131379
    Abstract: The present disclosure provides anti-transferrin receptor antibodies, compositions comprising the same and methods of their use. This disclosure also provides polynucleotides and vectors encoding the anti-transferrin receptor antibodies and cells comprising the same, methods of making the antibodies, and molecules comprising the antibodies.
    Type: Application
    Filed: August 31, 2022
    Publication date: April 27, 2023
    Inventors: Isin Dalkilic-Liddle, Benjamin A. Smith, Karl J. M. Hanf, Fang Qian, R. Blake Pepinsky, Thomas O. Cameron
  • HUMANIZED ANTI-ALPHA V BETA 5 ANTIBODIES AND USES THEREOF
    Publication number: 20170362324
    Abstract: Humanized antibodies and antibody fragments that bind to ?v?5 are disclosed. Also disclosed are methods of using the disclosed antibodies and antibody fragments to treat or prevent ?v?5-mediated diseases.
    Type: Application
    Filed: September 11, 2015
    Publication date: December 21, 2017
    Inventors: Thomas Owen Cameron, Michael Adam Crackower, Brian M. Dolinski, Karl J.M. Hanf, Amy Theresa McCurley, Nels Eric Pederson, Martin Preyer, Fang Qian, Shelia M. Violette, Paul Henry Weinreb
  • ANTI-CD154 ANTIBODIES
    Publication number: 20140220031
    Abstract: The present invention provides peptides, and fragments thereof, and antibodies, or fragments thereof comprising the same, wherein the peptide comprises at least one amino acid substitution compared to wild type 5c8 antibody. The present invention also provides compositions and methods of treating CD154-related diseases or disorders in a subject.
    Type: Application
    Filed: December 19, 2013
    Publication date: August 7, 2014
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Herman Van Vlijmen, Alexey Alexandrovic Lugovskoy, Karl J.M. Hanf
  • Anti-CD154 antibodies
    Patent number: 8647625
    Abstract: The present invention provides peptides, and fragments thereof, and antibodies, or fragments thereof comprising the same, wherein the peptide comprises at least one amino acid substitution compared to wild type 5c8 antibody. The present invention also provides compositions and methods of treating CD154-related diseases or disorders in a subject.
    Type: Grant
    Filed: July 26, 2005
    Date of Patent: February 11, 2014
    Assignee: Biogen Idec MA Inc.
    Inventors: Herman Van Vlijmen, Alexey Alexandrovic Lugovskoy, Karl J. M. Hanf
  • Anti-Cd154 Antibodies
    Publication number: 20080305116
    Abstract: The present invention provides peptides, and fragments thereof, and antibodies, or fragments thereof comprising the same, wherein the peptide comprises at least one amino acid substitution compared to wild type 5c8 antibody. The present invention also provides compositions and methods of treating CD154-related diseases or disorders in a subject.
    Type: Application
    Filed: July 26, 2005
    Publication date: December 11, 2008
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Herman Van Vlijmen, Alexey Alexandrovic Lugovskoy, Karl J.M. Hanf